MyFinsight
Home
Blog
About
Cash and cash
equivalents
$9,189K
(51.41%↑ Y/Y)
Prepaid and other
current assets
$3,538K
(-3.04%↓ Y/Y)
Royalty receivable,
current portion
$3,394K
(-9.32%↓ Y/Y)
Total current assets
$16,121K
(19.76%↑ Y/Y)
Royalty receivable,
long term
$12,626K
(-14.92%↓ Y/Y)
Right of use assets,
net
$4,828K
(-15.77%↓ Y/Y)
License rights and other
intangible assets, net
$3,559K
(-11.97%↓ Y/Y)
Other non-current
assets
$395K
(-7.71%↓ Y/Y)
Total assets
$37,529K
(-2.53%↓ Y/Y)
Total liabilities and
stockholders equity
$37,529K
(-2.53%↓ Y/Y)
Total stockholders
equity
$27,132K
(-0.59%↓ Y/Y)
Total liabilities
$10,397K
(-7.27%↓ Y/Y)
Accumulated deficit
-$952,141K
(-0.02%↓ Y/Y)
Additional paid-in capital
$979,262K
(0.01%↑ Y/Y)
Total current
liabilities
$5,003K
(7.31%↑ Y/Y)
Operating lease
liabilities
$4,521K
(-20.93%↓ Y/Y)
Other non-current
liabilities
$873K
(4.93%↑ Y/Y)
Common stock, par value
0.001 640,000 and...
$11K
(0.00%↑ Y/Y)
Current liabilities of
discontinued operations
$2,667K
(-2.02%↓ Y/Y)
Accrued expenses and
other current...
$1,876K
(17.99%↑ Y/Y)
Accounts payable
$460K
(31.43%↑ Y/Y)
Back
Back
Balance Sheet
TherapeuticsMD, Inc. (TXMD)
TherapeuticsMD, Inc. (TXMD)
source: myfinsight.com